Trademark Overview
On Wednesday, January 22, 2025, a trademark application was filed for KNEU HEALTH with the United States Patent and Trademark Office. The USPTO has given the KNEU HEALTH trademark a serial number of 99014587. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 22, 2025. This trademark is owned by Neuhealth Digital Limited. The KNEU HEALTH trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable software for use in health monitoring; Downloadable Software as a Medical Device (SaMD) for treating neurological conditions; Downloadable computer software for use in managing medical support systems; Downloadable software for use in operating and managing devices and instruments that measure, detect, and monitor health functions; Downloadable software for image capture; Downloadable software for detection and management of chronic neurological conditions; Downloadable software for monitoring and management of neurodegenerative conditions including Parkinson’s disease and dementia; Downloadable software for providing educational resources, support with medication adherence and symptom tracking of neurological conditions
Medical services; Healthcare; Health screening services in the field of neurodegenerative conditions including Parkinson’s disease and dementia; Providing medical information; Providing personalized healthcare and medical information in the nature of information relating to medical treatments; Providing personalized healthcare and medical information in the nature of information concerning surgery or therapy on the human body
Medical apparatus and instruments for use in neurological procedures; Medical apparatus and instruments for monitoring neurodegenerative conditions including Parkinson’s disease and dementia; Medical diagnostic apparatus for testing neurodegenerative conditions including Parkinson’s disease and dementia